U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 21-27, 2018
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 21-27, 2018

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 10/22/2018
Location: Silver Spring, MD
Subject: Viva White Oak Groundbreaking Ceremeony
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Government, industry, media, and other invited guests

Event Date: 10/23/2018
Location: Washington, DC
Subject: Joint FDA-USDA Public Meeting on the Use of Cell Culture Technology to Develop Products Derived From Livestock and Poultry
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Government, industry, media, and other registered guests

Event Date: 10/24/2018
Location: Washington, DC
Subject: Future of Health Summit: Celebrating Public Health and Medical Research Progress and Charting a Course for the Future
FDA Participant/Group: NINA DEVLIN; JEFFREY SHUREN;
Non FDA Participant/Group: Government, academia, industry, and other invited guests

Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/24/2018
Location: Philadelphia, PA
Subject: TransCelerate Realization Summit: Perspectives on Industry Challenges, Solutions, and the Impact of Collaboration
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 10/24/2018
Location: Washington, D.C.
Subject: Future of Health Summit: System Thinking to Drive Patient Engagement: Walking the Talk
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/23/2018
Location: Bethesda, MD
Subject: Parenteral Drug Association Cell and Gene Therapy Conference: FDA’s Efforts to Advance the Development of Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from manufacturing, product development, quality, research and development, regulatory affairs, engineering, information technology, validation, training, and clinical organizations

Event Date: 10/24/2018
Location: New York, NY
Subject: New York Stem Cell Foundation Conference: FDA’s Efforts to Advance the Development of Stem Cell Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from academia, industry, government, non-profits, and patient groups

Event Date: 10/25/2018
Location: New York, NY
Subject: The 9th Galien Forum: The Promise of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives and biomedical experts from industry, academia and government

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 10/23/2018
Location: Rockville, MD
Subject: The Association of American Feed Control Officials: Board of Directors Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several board members from the Association of American Feed Control Officials

Event Date: 10/25/2018
Location: Rockville, MD
Subject: American Veterinary Medical Association (AVMA) Quarterly Meeting: CVM Issues of Mutual Interest
FDA Participant/Group: AMY NEAL; HESHA JANI DUGGIRALA; MATTHEW LUCIA; MARGARET OELLER; NADINE NANKO; NEAL BATALLER; NADINE STEINBERG; SIOBHAN DELANCEY; ERIC NELSON; WILLIAM FLYNN; CINDY BURNSTEEL; MICHAEL MURPHY; ELLEN HART; LEE ANNE PALMER; TRACEY FORFA; RANDALL GNATT; PATRICK MCDERMOTT; JOHN BAKER; MARTINE HARTOGENSIS; PATRICE BROOKS-GELLING;
Non FDA Participant/Group: Ashley Morgan, Gail Golab, Kent McClure, Lauren Stump, Mark Lutschaunig (American Veterinary Medical Association );

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 10/21/2018
Location: Chengdu, China
Subject: 6th International Experimental Biology and Medicine Conference (IEBMC): Biomarkers and Emerging Technologies/Bioinformatics
FDA Participant/Group: WEIDA TONG;
Non FDA Participant/Group: N/A

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event